Molecular biomedicine

Keyphrases

Publications

volume 5, number 1, 2024

Yali Nie, Chao Song, Hong Huang, Shuqing Mao, Kai Ding, Huifang Tang
Chromatin modifiers in human disease: from functional roles to regulatory mechanisms. Molecular biomedicine 5 (1) (2024)
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, Aaron O Bailey, Gabriela N F Faria, Patrick McKernan, Wajeeha Razaq, Roger G Harrison
Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer. Molecular biomedicine 5 (1) (2024)
Chehao Lee, Yuqing Liang, Yang Li
Structural and functional insights of NINJ1 in plasma membrane rupture during cell death. Molecular biomedicine 5 (1) (2024)
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, Hongliang Zhang, Songquan Wu, Jianbin Ruan, Ying Zhou, Teng-Chuan Jin
NLRP inflammasomes in health and disease. Molecular biomedicine 5 (1) (2024)
Mrinal Kanti Ghosh, Srija Roy
Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling. Molecular biomedicine 5 (1) (2024)
Yali Nie, Chao Song, Hong Huang, Shuqing Mao, Kai Ding, Huifang Tang
Chromatin modifiers in human disease: from functional roles to regulatory mechanisms. Molecular biomedicine 5 (1) (2024)
Junyu Wang, Anren Zhang, Min Wu, Shugang Qin
Manipulating mitochondrial electron flow: a novel approach to enhance tumor immunogenicity. Molecular biomedicine 5 (1) (2024)
Junyu Wang, Anren Zhang, Min Wu, Shugang Qin
Manipulating mitochondrial electron flow: a novel approach to enhance tumor immunogenicity. Molecular biomedicine 5 (1) (2024)
Yuhao Yao, Zhi Zong, Jisheng Liu
Unlocking γδ T cell power: pathways that boost cancer defense. Molecular biomedicine 5 (1) (2024)
Mrinal Kanti Ghosh, Srija Roy
Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling. Molecular biomedicine 5 (1) (2024)
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, Hongliang Zhang, Songquan Wu, Jianbin Ruan, Ying Zhou, Teng-Chuan Jin
NLRP inflammasomes in health and disease. Molecular biomedicine 5 (1) (2024)
Masoud Mozafari
Biomaterials barcoding: a high-throughput breakthrough. Molecular biomedicine 5 (1) (2024)
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, Hongliang Zhang, Songquan Wu, Jianbin Ruan, Ying Zhou, Teng-Chuan Jin
NLRP inflammasomes in health and disease. Molecular biomedicine 5 (1) (2024)
Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei Lu
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 5 (1) (2024)
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, Hongliang Zhang, Songquan Wu, Jianbin Ruan, Ying Zhou, Teng-Chuan Jin
NLRP inflammasomes in health and disease. Molecular biomedicine 5 (1) (2024)
Xi Wu, Yuan Fang, Yunru Gu, Haoyang Shen, Yangyue Xu, Tingting Xu, Run Shi, Duo Xu, Jingxin Zhang, Kai Leng, Yongqian Shu, Pei Ma
Fat mass and obesity-associated protein (FTO) mediated m 6 A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay. Molecular biomedicine 5 (1) (2024)
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, Aaron O Bailey, Gabriela N F Faria, Patrick McKernan, Wajeeha Razaq, Roger G Harrison
Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer. Molecular biomedicine 5 (1) (2024)
Chehao Lee, Yuqing Liang, Yang Li
Structural and functional insights of NINJ1 in plasma membrane rupture during cell death. Molecular biomedicine 5 (1) (2024)
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, Aaron O Bailey, Gabriela N F Faria, Patrick McKernan, Wajeeha Razaq, Roger G Harrison
Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer. Molecular biomedicine 5 (1) (2024)
Yuhao Yao, Zhi Zong, Jisheng Liu
Unlocking γδ T cell power: pathways that boost cancer defense. Molecular biomedicine 5 (1) (2024)
Shanqiang Qu, Rongyang Xu, Guozhong Yi, Zhiyong Li, Huayang Zhang, Song-Tao Qi, Guang-Long Huang
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine. Molecular biomedicine 5 (1) (2024)
Mrinal Kanti Ghosh, Srija Roy
Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling. Molecular biomedicine 5 (1) (2024)
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, Aaron O Bailey, Gabriela N F Faria, Patrick McKernan, Wajeeha Razaq, Roger G Harrison
Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer. Molecular biomedicine 5 (1) (2024)
Min Tao, Yingfeng Shi, Hui Chen, Jinqing Li, Yi Wang, Xiaoyan Ma, Lin Du, Yishu Wang, Xinyu Yang, Yan Hu, Xun Zhou, Qin Zhong, Danying Yan, Andong Qiu, Shougang Zhuang, Na Liu
The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases. Molecular biomedicine 5 (1) (2024)
Masoud Mozafari
Biomaterials barcoding: a high-throughput breakthrough. Molecular biomedicine 5 (1) (2024)
Jie Wang, Fan Jiang, Peng Cheng, Zhaoyang Ye, Linsheng Li, Ling Yang, Li Zhuang, Wen-Ping Gong
Construction of novel multi-epitope-based diagnostic biomarker HP16118P and its application in the differential diagnosis of Mycobacterium tuberculosis latent infection. Molecular biomedicine 5 (1) (2024)
Masoud Mozafari
Biomaterials barcoding: a high-throughput breakthrough. Molecular biomedicine 5 (1) (2024)
Jie Wang, Fan Jiang, Peng Cheng, Zhaoyang Ye, Linsheng Li, Ling Yang, Li Zhuang, Wen-Ping Gong
Construction of novel multi-epitope-based diagnostic biomarker HP16118P and its application in the differential diagnosis of Mycobacterium tuberculosis latent infection. Molecular biomedicine 5 (1) (2024)
Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei Lu
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 5 (1) (2024)
Jie Wang, Fan Jiang, Peng Cheng, Zhaoyang Ye, Linsheng Li, Ling Yang, Li Zhuang, Wen-Ping Gong
Construction of novel multi-epitope-based diagnostic biomarker HP16118P and its application in the differential diagnosis of Mycobacterium tuberculosis latent infection. Molecular biomedicine 5 (1) (2024)
Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei Lu
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 5 (1) (2024)
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, Hongliang Zhang, Songquan Wu, Jianbin Ruan, Ying Zhou, Teng-Chuan Jin
NLRP inflammasomes in health and disease. Molecular biomedicine 5 (1) (2024)
Yali Nie, Chao Song, Hong Huang, Shuqing Mao, Kai Ding, Huifang Tang
Chromatin modifiers in human disease: from functional roles to regulatory mechanisms. Molecular biomedicine 5 (1) (2024)
Yu Tao, Li Wei, Norio Shiba, Daisuke Tomizawa, Yasuhide Hayashi, Seishi Ogawa, Li Chen, Hua You
Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia. Molecular biomedicine 5 (1) (2024)
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, Aaron O Bailey, Gabriela N F Faria, Patrick McKernan, Wajeeha Razaq, Roger G Harrison
Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer. Molecular biomedicine 5 (1) (2024)
Xi Wu, Yuan Fang, Yunru Gu, Haoyang Shen, Yangyue Xu, Tingting Xu, Run Shi, Duo Xu, Jingxin Zhang, Kai Leng, Yongqian Shu, Pei Ma
Fat mass and obesity-associated protein (FTO) mediated m 6 A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay. Molecular biomedicine 5 (1) (2024)
Xi Wu, Yuan Fang, Yunru Gu, Haoyang Shen, Yangyue Xu, Tingting Xu, Run Shi, Duo Xu, Jingxin Zhang, Kai Leng, Yongqian Shu, Pei Ma
Fat mass and obesity-associated protein (FTO) mediated m 6 A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay. Molecular biomedicine 5 (1) (2024)
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, Aaron O Bailey, Gabriela N F Faria, Patrick McKernan, Wajeeha Razaq, Roger G Harrison
Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer. Molecular biomedicine 5 (1) (2024)
Lincheng Zhang, Peng Liu, Li Zhuang, Sunbin Ling, Qifan Zhan, Wei Zhou, Renyi Su, Lu Yin, Qingyang Que, Jiachen Hong, Jiaqi Bao, Chuxiao Shao, Jinzhen Cai, Shushen Zhen, Xiao Xu
mTOR inhibitor reduces nontumour-related death in liver transplantation for hepatocellular carcinoma. Molecular biomedicine 5 (1) (2024)
Lincheng Zhang, Peng Liu, Li Zhuang, Sunbin Ling, Qifan Zhan, Wei Zhou, Renyi Su, Lu Yin, Qingyang Que, Jiachen Hong, Jiaqi Bao, Chuxiao Shao, Jinzhen Cai, Shushen Zhen, Xiao Xu
mTOR inhibitor reduces nontumour-related death in liver transplantation for hepatocellular carcinoma. Molecular biomedicine 5 (1) (2024)
Chehao Lee, Yuqing Liang, Yang Li
Structural and functional insights of NINJ1 in plasma membrane rupture during cell death. Molecular biomedicine 5 (1) (2024)
Masoud Mozafari
Biomaterials barcoding: a high-throughput breakthrough. Molecular biomedicine 5 (1) (2024)
Yuhao Yao, Zhi Zong, Jisheng Liu
Unlocking γδ T cell power: pathways that boost cancer defense. Molecular biomedicine 5 (1) (2024)
Shanqiang Qu, Rongyang Xu, Guozhong Yi, Zhiyong Li, Huayang Zhang, Song-Tao Qi, Guang-Long Huang
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine. Molecular biomedicine 5 (1) (2024)
Mrinal Kanti Ghosh, Srija Roy
Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling. Molecular biomedicine 5 (1) (2024)
Min Tao, Yingfeng Shi, Hui Chen, Jinqing Li, Yi Wang, Xiaoyan Ma, Lin Du, Yishu Wang, Xinyu Yang, Yan Hu, Xun Zhou, Qin Zhong, Danying Yan, Andong Qiu, Shougang Zhuang, Na Liu
The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases. Molecular biomedicine 5 (1) (2024)
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, Aaron O Bailey, Gabriela N F Faria, Patrick McKernan, Wajeeha Razaq, Roger G Harrison
Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer. Molecular biomedicine 5 (1) (2024)
Min Tao, Yingfeng Shi, Hui Chen, Jinqing Li, Yi Wang, Xiaoyan Ma, Lin Du, Yishu Wang, Xinyu Yang, Yan Hu, Xun Zhou, Qin Zhong, Danying Yan, Andong Qiu, Shougang Zhuang, Na Liu
The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases. Molecular biomedicine 5 (1) (2024)
Yu Tao, Li Wei, Norio Shiba, Daisuke Tomizawa, Yasuhide Hayashi, Seishi Ogawa, Li Chen, Hua You
Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia. Molecular biomedicine 5 (1) (2024)
Yu Tao, Li Wei, Norio Shiba, Daisuke Tomizawa, Yasuhide Hayashi, Seishi Ogawa, Li Chen, Hua You
Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia. Molecular biomedicine 5 (1) (2024)